Claims for Patent: 8,907,099
✉ Email this page to a colleague
Summary for Patent: 8,907,099
| Title: | Nitrocatechol derivatives as COMT inhibitors |
| Abstract: | New compounds of formula I are described. The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders. |
| Inventor(s): | David Alexander Learmonth, Laszlo Erno Kiss, Pedro Nuno Leal Palma, Humberto Dos Santos Ferreira, Patricio Manuel Vieira Araújo Soares Da Silva |
| Assignee: | Bial Portela and Cia SA |
| Application Number: | US13/442,356 |
| Patent Claims: |
1. A compound according to formula IVA, IVB or IVC wherein R4, R5, R6 and R7 independently from each other represent hydrogen, C1-C6-alkyl, C1-C6-thioalkyl, C1-C6-alkoxy, C6-C12-aryloxy or a C6-C12-thioaryl group, C1-C6-alkanoyl or C7-C13-aroyl group, amino, C1-C6-alkylamino, C1-C6-dialkylamino, C3-C12-cycloalkylamino or C3-C12-heterocycloalkylamino, C1-C6-alkylsulphonyl or C6-C12-arylsulphonyl, halogen, C1-C6-haloalkyl, trifluoromethyl, cyano, nitro or a heteroaryl group; and R8 and R9 independently from each other represent hydrogen or suitable protective groups for aromatic hydroxyl groups. 2. A compound according to claim 1 wherein the suitable protective groups for aromatic hydroxyl groups are selected from methyl, ethyl, isopropyl, benzyl, 4-methoxybenzyl, methoxymethyl, benzyloxymethyl, methoxyethoxymethyl, tetrahydropyranyl, phenacyl, allyl, trimethylsilyl, tert-butyldimethylsilyl, benzyloxycarbonyl, tert-butoxycarbonyl, ester, sulphonate, carbamate, phosphinate, acetal and ketal derivatives. 3. A compound according to claim 1, wherein one of the groups R8 and R9 is hydrogen and the other is methyl. 4. A compound according to claim 1, wherein R8 represents methyl and R9 represents hydrogen. 5. A compound according to formula VIA, VIB or VIC wherein R4, R5, R6 and R7 independently from each other represent hydrogen, C1-C6-alkyl, C1-C6-thioalkyl, C1-C6-alkoxy, C6-C12-aryloxy or a C6-C12-thioaryl group, C1-C6-alkanoyl or C7-C13-aroyl group, amino, C1-C6-alkylamino, C1-C6-dialkylamino, C3-C12-cycloalkylamino or C3-C12-heterocycloalkylamino, C1-C6-alkylsulphonyl or C6-C12-arylsulphonyl, halogen, C1-C6-haloalkyl, trifluoromethyl, cyano, nitro or a heteroaryl group; and R8 and R9 independently from each other represent hydrogen or suitable protective groups for aromatic hydroxyl groups. 6. A compound according to claim 5 wherein the suitable protective groups for aromatic hydroxyl groups are selected from methyl, ethyl, isopropyl, benzyl, 4-methoxybenzyl, methoxymethyl, benzyloxymethyl, methoxyethoxymethyl, tetrahydropyranyl, phenacyl, allyl, trimethylsilyl, tert-butyldimethylsilyl, benzyloxycarbonyl, tert-butoxycarbonyl, ester, sulphonate, carbamate, phosphinate, acetal and ketal derivatives. 7. A compound according to claim 5 wherein one of the groups R8 and R9 is hydrogen and the other is methyl. 8. A compound according to claim 5 wherein R8 represents methyl and R9 represents hydrogen. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
